BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 15899879)

  • 1. The noncatalytic amino terminus of mitogen-activated protein kinase phosphatase 1 directs nuclear targeting and serum response element transcriptional regulation.
    Wu JJ; Zhang L; Bennett AM
    Mol Cell Biol; 2005 Jun; 25(11):4792-803. PubMed ID: 15899879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The MAPK/ERK cascade targets both Elk-1 and cAMP response element-binding protein to control long-term potentiation-dependent gene expression in the dentate gyrus in vivo.
    Davis S; Vanhoutte P; Pages C; Caboche J; Laroche S
    J Neurosci; 2000 Jun; 20(12):4563-72. PubMed ID: 10844026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
    Hutter D; Chen P; Barnes J; Liu Y
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role for mitogen-activated protein (MAP) kinase phosphatase-1 in stress-responsive MAP kinase and cell survival signaling.
    Wu JJ; Bennett AM
    J Biol Chem; 2005 Apr; 280(16):16461-6. PubMed ID: 15722358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1.
    Slack DN; Seternes OM; Gabrielsen M; Keyse SM
    J Biol Chem; 2001 May; 276(19):16491-500. PubMed ID: 11278799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
    Wu W; Pew T; Zou M; Pang D; Conzen SD
    J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation.
    Misra-Press A; Rim CS; Yao H; Roberson MS; Stork PJ
    J Biol Chem; 1995 Jun; 270(24):14587-96. PubMed ID: 7782322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses.
    Chi H; Barry SP; Roth RJ; Wu JJ; Jones EA; Bennett AM; Flavell RA
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2274-9. PubMed ID: 16461893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharide-induced cyclooxygenase-2 expression in RAW 264.7 cells.
    Chen TH; Kao YC; Chen BC; Chen CH; Chan P; Lee HM
    Eur J Pharmacol; 2006 Jul; 541(3):138-46. PubMed ID: 16765938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling.
    Lin YW; Yang JL
    J Biol Chem; 2006 Jan; 281(2):915-26. PubMed ID: 16286470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW; Shi YY; Higgins LS; Orlowski RZ
    Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MKP-7, a novel mitogen-activated protein kinase phosphatase, functions as a shuttle protein.
    Masuda K; Shima H; Watanabe M; Kikuchi K
    J Biol Chem; 2001 Oct; 276(42):39002-11. PubMed ID: 11489891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive MAP kinase phosphatase (MKP-1) expression blocks G1 specific gene transcription and S-phase entry in fibroblasts.
    Brondello JM; McKenzie FR; Sun H; Tonks NK; Pouysségur J
    Oncogene; 1995 May; 10(10):1895-904. PubMed ID: 7761091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carboxyl-terminal domains of MKP-1 and MKP-2 have inhibitory effects on their phosphatase activity.
    Hutter D; Chen P; Li J; Barnes J; Liu Y
    Mol Cell Biochem; 2002 Apr; 233(1-2):107-17. PubMed ID: 12083364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypoxia on the expression and activity of mitogen-activated protein (MAP) kinase-phosphatase-1 (MKP-1) and MKP-3 in neuronal nuclei of newborn piglets: the role of nitric oxide.
    Mishra OP; Delivoria-Papadopoulos M
    Neuroscience; 2004; 129(3):665-73. PubMed ID: 15541888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase Cdelta-mediated proteasomal degradation of MAP kinase phosphatase-1 contributes to glutamate-induced neuronal cell death.
    Choi BH; Hur EM; Lee JH; Jun DJ; Kim KT
    J Cell Sci; 2006 Apr; 119(Pt 7):1329-40. PubMed ID: 16537649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular signal-regulated kinase (ERK) controls immediate early gene induction on corticostriatal stimulation.
    Sgambato V; Pagès C; Rogard M; Besson MJ; Caboche J
    J Neurosci; 1998 Nov; 18(21):8814-25. PubMed ID: 9786988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Bazuine M; Carlotti F; Tafrechi RS; Hoeben RC; Maassen JA
    Mol Endocrinol; 2004 Jul; 18(7):1697-707. PubMed ID: 15184525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death.
    Zhou JY; Liu Y; Wu GS
    Cancer Res; 2006 May; 66(9):4888-94. PubMed ID: 16651445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.